Viewing Study NCT05217303


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-01-04 @ 4:18 PM
Study NCT ID: NCT05217303
Status: COMPLETED
Last Update Posted: 2023-05-31
First Post: 2022-01-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: HL-085 in NRAS-mutated Advanced Melanoma
Sponsor: Shanghai Kechow Pharma, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HL-085 View
None MEK inhibitor View
None NRAS mutation View
None advanced melanoma View